S&P Global Upgrades Biocon Biologics Credit Rating To ‘BB+’; Revises Outlook to…
Bengaluru: Biocon Biologics Limited, a fully integrated, global biosimilars company and subsidiary of Biocon Ltd. (BSE: 532523, NSE: BIOCON), today announced that S&P Global Ratings has!-->…